Washington, D.C. 20549

                                    FORM 8-K

                                 Current Report

                       Pursuant to Section 13 or 15(d) of
                      the Securities and Exchange Act 1934

Date of Report (Date of earliest event reported):    April 30, 2009

                            IntegraMed America, Inc.
               (Exact name of registrant as specified in charter)

                 (State of other jurisdiction of incorporation)

             0-20260                                  6-1150326
     (Commission File Numbers)            (IRS Employer Identification No.)

Two Manhattanville Road, Purchase, NY                   10577
(Address of principal executive offices)             (Zip Code)

Registrant's telephone no. including area code: (914) 253-8000

(Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

        Written communication  pursuant to Rule 425 under the Securities Act (17
     __ CFR 230.425)

        Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17
     __ CFR 240.14a-12)

        Pre-commencement  communication  pursuant  to Rule  14d-2(b)  under  the
     __ Exchange Act (17 CFR 240.14d-2(b)

        Pre-commencement  communication  pursuant  to Rule  13e-4(c)  under  the
     __ Exchange Act (17 CFR 240.13e-4(c))

ITEM 2.02  Results of Operations and Financial Condition

           On April 30, 2009,  Registrant  filed a press  release,  which is
attached hereto as exhibit 99.1 and incorporated herein by reference.

ITEM 9.01  Financial Statements, Pro Forma Financial Information and Exhibits

           (c)  Exhibits

                Exhibit No.  Description of Exhibit
                -----------  ----------------------
                99.1         Registrant's Press Release dated April 30, 2009.


           Pursuant to the requirements of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                            IntegraMed America, Inc.

Date:    April 30, 2009                  By: /s/John W. Hlywak, Jr.
                                                   John W. Hlywak, Jr.
                                                   Executive Vice President and
                                                   Chief Financial Officer
                                                   (Principal Financial and
                                                   Accounting Officer)